BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 16185718)

  • 1. Toxigenic C. difficile induced inflammatory marker expression by human intestinal epithelial cells is asymmetrical.
    Canny G; Drudy D; Macmathuna P; O'farrelly C; Baird AW
    Life Sci; 2006 Jan; 78(9):920-5. PubMed ID: 16185718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of varying concentrations of clostridium difficile toxin A on epithelial barrier function and expression of cytokines.
    Johal SS; Solomon K; Dodson S; Borriello SP; Mahida YR
    J Infect Dis; 2004 Jun; 189(11):2110-9. PubMed ID: 15143480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NF-kappa B activation pathway is essential for the chemokine expression in intestinal epithelial cells stimulated with Clostridium difficile toxin A.
    Kim JM; Lee JY; Yoon YM; Oh YK; Youn J; Kim YJ
    Scand J Immunol; 2006 Jun; 63(6):453-60. PubMed ID: 16764699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucosamine suppresses interleukin-8 production and ICAM-1 expression by TNF-alpha-stimulated human colonic epithelial HT-29 cells.
    Yomogida S; Hua J; Sakamoto K; Nagaoka I
    Int J Mol Med; 2008 Aug; 22(2):205-11. PubMed ID: 18636175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Yeast, beef and pork extracts counteract Clostridium difficile toxin A enterotoxicity.
    Duncan PI; Fotopoulos G; Pasche E; Porta N; Masserey Elmelegy I; Sanchez-Garcia JL; Bergonzelli GE; Corthésy-Theulaz I
    FEMS Microbiol Lett; 2009 Jun; 295(2):218-25. PubMed ID: 19416358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clostridium difficile toxin A-induced colonocyte apoptosis involves p53-dependent p21(WAF1/CIP1) induction via p38 mitogen-activated protein kinase.
    Kim H; Kokkotou E; Na X; Rhee SH; Moyer MP; Pothoulakis C; Lamont JT
    Gastroenterology; 2005 Dec; 129(6):1875-88. PubMed ID: 16344056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clostridium difficile toxin A stimulates macrophage-inflammatory protein-2 production in rat intestinal epithelial cells.
    Castagliuolo I; Keates AC; Wang CC; Pasha A; Valenick L; Kelly CP; Nikulasson ST; LaMont JT; Pothoulakis C
    J Immunol; 1998 Jun; 160(12):6039-45. PubMed ID: 9637520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human mucosa/submucosa interactions during intestinal inflammation: involvement of the enteric nervous system in interleukin-8 secretion.
    Tixier E; Lalanne F; Just I; Galmiche JP; Neunlist M
    Cell Microbiol; 2005 Dec; 7(12):1798-810. PubMed ID: 16309465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clostridium difficile-derived membrane vesicles induce the expression of pro-inflammatory cytokine genes and cytotoxicity in colonic epithelial cells in vitro.
    Nicholas A; Jeon H; Selasi GN; Na SH; Kwon HI; Kim YJ; Choi CW; Kim SI; Lee JC
    Microb Pathog; 2017 Jun; 107():6-11. PubMed ID: 28284851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of inducible cyclooxygenase and prostaglandins in Clostridium difficile toxin A-induced secretion and inflammation in an animal model.
    Alcantara C; Stenson WF; Steiner TS; Guerrant RL
    J Infect Dis; 2001 Sep; 184(5):648-52. PubMed ID: 11474431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clostridium difficile toxin: cytoskeletal changes and lactate dehydrogenase release in hepatocytes.
    Grossmann EM; Longo WE; Kaminski DL; Smith GS; Murphy CE; Durham RL; Shapiro MJ; Norman JG; Mazuski JE
    J Surg Res; 2000 Feb; 88(2):165-72. PubMed ID: 10644484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of host defenses on Clostridium difficile toxin-induced intestinal barrier injury.
    Olson A; Diebel LN; Liberati DM
    J Trauma Acute Care Surg; 2013 Apr; 74(4):983-89; discussion 989-90. PubMed ID: 23511135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clostridium difficile toxins facilitate bacterial colonization by modulating the fence and gate function of colonic epithelium.
    Kasendra M; Barrile R; Leuzzi R; Soriani M
    J Infect Dis; 2014 Apr; 209(7):1095-104. PubMed ID: 24273043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxin A-negative, toxin B-positive Clostridium difficile.
    Drudy D; Fanning S; Kyne L
    Int J Infect Dis; 2007 Jan; 11(1):5-10. PubMed ID: 16857405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repetitive domain of Clostridium difficile toxin B exhibits cytotoxic effects on human intestinal epithelial cells and decreases epithelial barrier function.
    Zemljic M; Rupnik M; Scarpa M; Anderluh G; Palù G; Castagliuolo I
    Anaerobe; 2010 Oct; 16(5):527-32. PubMed ID: 20620216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clostridium difficile toxin B is an inflammatory enterotoxin in human intestine.
    Savidge TC; Pan WH; Newman P; O'brien M; Anton PM; Pothoulakis C
    Gastroenterology; 2003 Aug; 125(2):413-20. PubMed ID: 12891543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human intestinal epithelial response(s) to Clostridium difficile.
    Jafari NV; Allan E; Bajaj-Elliott M
    Methods Mol Biol; 2010; 646():135-46. PubMed ID: 20597007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clostridium difficile toxin A. Interactions with mucus and early sequential histopathologic effects in rabbit small intestine.
    Lima AA; Innes DJ; Chadee K; Lyerly DM; Wilkins TD; Guerrant RL
    Lab Invest; 1989 Oct; 61(4):419-25. PubMed ID: 2507823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exogenous phosphatidylcholine supplementation improves intestinal barrier defense against Clostridium difficile toxin.
    Olson A; Diebel LN; Liberati DM
    J Trauma Acute Care Surg; 2014 Oct; 77(4):570-5; discussion 576. PubMed ID: 25250596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro effects of Clostridium difficile toxins on hepatocytes.
    Mazuski JE; Panesar N; Tolman K; Longo WE
    J Surg Res; 1998 Oct; 79(2):170-8. PubMed ID: 9758734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.